|
1. The 5-domain NPCCSS scale is the first choice for assessing clinical severity of NPC in routine clinical practice
|
68% (13)
|
32% (6)
|
|
2. The 17-domain NPCCSS scale is the first choice for assessing clinical severity of NPC in clinical trial settings, prioritising the domains in the 5-domain scale (e.g. as primary endpoints)
|
74% (14)
|
26% (5)
|
|
3. There is no need for a new universal scale for all settings to be developed
|
74% (14)
|
26% (5)
|
|
4. Resources/training on how to apply the NPCCSS (17- and 5-domains) should be developed and provided to clinicians working in NPC
|
89% (17)
|
11% (2)
|
|
5. The consensus paper is reviewed periodically to ensure that its recommendations remain accurate
|
100% (19)
|
0% (0)
|
|
6. The timescale for periodic review of the consensus paper should be every 5 years
|
84% (16)
|
16% (3)
|
